Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Trice Medical

Request full access

Founded to fundamentally improve orthopedic diagnostics for the patient

Charlestown Township, United StatesFounded 2011Health Tech & Medtech

About Trice Medical

Trice Medical, established in 2011 by Jeffrey F. O'Donnell, Sr., operates within the orthopedic diagnostics sector, focusing on providing swift and cost-effective solutions for joint injury assessment. The company is headquartered in Malvern, Pennsylvania, and targets orthopedic surgeons, payers, and patients. Its business model centers on enabling physicians to perform diagnostic and therapeutic procedures in various settings, including the office, a procedure room, or an operating room, thereby reducing the time and costs associated with traditional diagnostic paths like MRIs.

Jeffrey O'Donnell is a serial entrepreneur with extensive experience in the medical device industry, having founded and led several companies to successful exits, including Embrella Cardiovascular and PhotoMedex. This background in leading emerging medical technology firms has been instrumental in shaping Trice Medical's trajectory. The current President and CEO, Mark Foster, joined in 2016 after holding leadership roles at Smith & Nephew and Boston Scientific, bringing over two decades of experience in the medical device field. His leadership has guided the company's evolution from a purely diagnostic focus to a broader therapeutic platform.

The company’s core technology is a portable, tablet-based imaging platform that combines handheld arthroscopy and ultrasound capabilities. Its flagship product family, the mi-eye, is a single-use, disposable needlescope that provides direct visualization inside a joint. The mi-eye 3, for instance, is an FDA-cleared needlescope with an integrated camera and light source that pairs with the mi-tablet, offering high-resolution imaging in a handheld device. This allows for immediate diagnosis during an initial office visit. Complementing the mi-eye is the mi-ultra, a handheld ultrasound transducer optimized for musculoskeletal applications, enabling a comprehensive evaluation of the joint and surrounding soft tissue, as well as guiding injections. Through strategic acquisitions, such as Seg-WAY Orthopedics in 2019 and Tenex Health in 2021, Trice Medical has expanded its portfolio to include minimally invasive therapeutic solutions. These include the Seg-WAY system for endoscopic carpal tunnel release and the Tenex Health TX technology, which uses ultrasonic energy to treat chronic tendon pain.

Source: Dealroom company data

At a glance

Status
Operational
Employees
52
Open positions
None listed
Dealroom signal
77.5/100
Industry
Health
Sub-industry
Medical Devices
Sector
Surgery, Cardiology and cardiovascular, Neurology, Medical Imaging, Orthopedic, Hard Tech, DT and LS, science-based
Technology
Deep Tech
Business model
Manufacturing
Client focus
B2B

Funding history

8 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
LATE VCOther financing Nov 2022 $7.3M $92M Undisclosed ↗
LATE VCOther financing Aug 2021 $0 — Bioventus —
Showing the latest 2 of 8 recorded eventsBook a demo for the full funding history →

Growth signals

Trice Medical website traffic

Latest recorded traffic for Trice Medical is 2.8K monthly website visits, up 7.7% over the last three months. Trice Medical's team declined 1.9% over the past year.

Latest monthly visits2.8K 3-month web change+7.7% 1-year team growth-1.9%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Showing 8 of the closest matchesCompare every metric →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

Trice Medical in the Charlestown Township ecosystem

Live from Dealroom

The Trice Medical office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

7 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A3 investors entered at this stage

  • BioStar Capital
  • Safeguard Scientifics
  • HealthQuest Capital

Series B and later4 investors entered at this stage

  • Smith & Nephew
  • Charter Capital Partners
  • Municipal Employee Retirement System
  • Bioventus
Team profiled 14 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 3 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

See Trice Medical’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.